Skip to main content
. 2017 Nov 28;4(4):ofx262. doi: 10.1093/ofid/ofx262

Figure 3.

Figure 3.

Kaplan-Meier (KM) estimates for the cumulative percentage of participants experiencing AIDS, serious non-AIDS, or death in START (4299). (A) Kaplan-Meier estimates for the cumulative percentage of participants experiencing an AIDS or AIDS-death (top row) and serious non-AIDS or non-AIDS death (bottom row) pooled over study groups by quartiles of D-dimer and IL-6 at baseline (first quartile = blue; second quartile = green; third quartile = orange; fourth quartile = red). The number at risk at each year of follow-up is presented below the x-axis. (B) Kaplan-Meier estimates for the cumulative percentage of participants experiencing the composite outcome of AIDS, serious non-AIDS or death in the immediate (red lines) and deferred (blue lines) ART groups in START, separately by whether baseline level of D-dimer and IL-6 were above (solid lines) or below (dashed lines) their median at baseline.